ACTRN12621000013864尚未招募未知
Evaluation of angiotensin II type 1 receptor (ATII-1R) concentration and correlation with incidence and severity of Coronavirus Disease 2019 (COVID-19) among physicians and nurses.
Patrycja Lesnik, MD, PhD0 个研究点目标入组 80 人开始时间: 2021年1月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Study group:
- •1.Age > 18 years old and < 75 years old
- •2.Physicians and nurses working with COVID-19 patients
- •3.Personnel with positive rt-PCR test result for SARS-CoV-2
- •4.The lack of severe systemic diseases precluding participation in the study
- •5.The obtained informed and written consent to participate in the study.
- •Control group:
- •1.Age > 18 years old and < 75 years old
- •2.Physicians and nurses working with COVID-19 patients
- •3.Personnel with negative rt-PCR test result for SARS-CoV-2
- •4.The lack of serious systemic diseases precluding participation in the study
- •5.The obtained informed and written consent to participate in the study
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Evaluation of the effect of AngiotensinII receptor blocker on coronary artery after Sirolimus-Eluting Stent implantatioJPRN-UMIN000001822Toyohashi Heart Ceter, Cardiovascular Medicine50
已完成
4 期
Therapeutic Efficacy of an Angiotensin II Receptor Antagonist in Patients with Nonalcoholic Steathepatitisonalcoholic steatohepatitisJPRN-C000000202Gunma Liver Study Group10
已完成
不适用
A Randomized Study of Angiotensin II Type 1 Receptor Blocker vs Dihydropidine Ca Antagonist for Treatment of Paroxysmal Atrial Fibrillation in Patients with HypertensioAtrial Fibrillation with HypertensionJPRN-C000000427The J-RHYTHM II Investigators400
已完成
4 期
ong-term Effects of an Angiotensin II Type 1 Receptor Blocker in Hypertensive Patients with Chronic Kidney Disease and Metabolic SyndromeHypertension Chronic kidney disease Metabolic syndromeJPRN-UMIN000010892Department of Cardiology Kinu Medical Association Hospital160
已完成
4 期
Study on quality use of angiotensin II receptor blockers -Comparison between valsartan and olmesartanhypertensionJPRN-UMIN000003776Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University150